BIAF (bioAffinity Technologies) Kacepetan wutah bathi saben saham ing taun lumaku

Simbol resmi perusahaan bioaffinitytech.com (BIAF)

Slow physician adoption of tests and marketing expenses previously constrained revenues for bioAffinity Technologies (BIAF). The volatility of annual earnings per share on the GURU.Markets chart currently reflects the present trend, where 0.00 indicates the level of this metric. Ahead lies the B2B expansion of the non-invasive CyPath Lung method, although patent disputes with tech startups will remain a key challenge.

BIAF (bioAffinity Technologies Inc.) riwayat Wutah bathi ing taun lumaku saka 28.04.2023 nganti 11.11.2026

Rincian analitis lan laporan data perusahaan bioaffinitytech.com (BIAF)

- rega lan prakiraan konsensus rega:
Kutipan saham bioAffinity Technologies, Inc.|BIAF - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar bioAffinity Technologies, Inc.|BIAF - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham bioAffinity Technologies|BIAF - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku bioaffinitytech.com|BIAF - Total Aset Perusahaan
- rincian utang lan likuiditas:
Koefisien Total Utang marang Modal bioAffinity Technologies|BIAF - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal bioAffinity Technologies, Inc.|BIAF - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku bioAffinity Technologies, Inc.|BIAF - Utang jangka dawa perusahaan|Kewajiban jangka cendhak bioAffinity Technologies|Rasio likuiditas kritis bioaffinitytech.com
- indikator pendapatan resik lan kelipatan nilai:
BIAF - Bathi resik|Prakiraan bathi perusahaan bioAffinity Technologies|BIAF - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep bioAffinity Technologies, Inc.|BIAF - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan bioAffinity Technologies, Inc.|BIAF - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan bioAffinity Technologies|BIAF - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan bioaffinitytech.com|BIAF - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep bioAffinity Technologies
Pambiji fundamental:bioAffinity Technologies
Produk seri bioAffinity Technologies

This metric measures the year-over-year dynamics of earnings per share, reflecting the efficiency of capital generation. For bioAffinity Technologies (BIAF), this growth depends directly on the commercialization of patented cancer tests and their recognition by insurance companies. Analyzing the year-over-year change in EPS allows investors to distinguish a speculative asset from a fundamentally sustainable business, confirming the actual strength of the economic moat.

Pesaing langsung

Wutah bathi resik saben saham ing taun iki ArriVent Corp|LTRN (Lantern Pharma Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku eEFFECTOR EFTR